Jaime H. Noguez

Jaime H. Noguez

Auto-generated profile, based on publicly available information

Jaime H. Noguez

Department of Pathology, Case Western Reserve University School of Medicine , Cleveland, OH

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018
Verified
Book Chapter
Closed access
SKSirisha Kundrapu
Sirisha Kundrapu
JNJaime Noguez
Jaime Noguez

20 December 2021 in Clinical Chemistry
Verified
Journal Article
Open access
PDF file
MMMark A Marzinke
Mark A Marzinke
DGDina N Greene
Dina N Greene
PBPatrick M Bossuyt
Patrick M Bossuyt
ACAllison B Chambliss
Allison B Chambliss
LCLauren Cirrincione
Lauren Cirrincione
MHMelanie P Hoenig
Melanie P Hoenig
Background: Commonly used estimated glomerular filtration rate (eGFR) equations include a Black race modifier (BRM) that was incorporated during equation derivation. Race is a social construct, and a poorly characterized variable that is applied inconsistently in clinical settings. The BRM results in higher eGFR for any creatinine concentration, implying fundamental differences in creatinine production or excretion in Black individuals compared to other populations. Equations without inclusion of the BRM have the potential to detect kidney disease earlier in patients at the greatest risk of chronic kidney disease (CKD), but also has the potential to over-diagnose CKD or impact downstream clinical interventions. The purpose of this study was to use an evidence-based approach to systematically evaluate the literature relevant to the performance of the eGFR equations with and without the BRM and to examine the clinical impact of the use or removal. Content: PubMed and Embase databases were searched for studies comparing measured GFR to eGFR in racially diverse adult populations using the Modification of Diet in Renal Disease or the 2009-Chronic Kidney Disease Epidemiology Collaboration-creatinine equations based on standardized creatinine measurements. Additionally, we searched for studies comparing clinical use of eGFR calculated with and without the BRM. Here, 8632 unique publications were identified; an additional 3 studies were added post hoc. In total, 96 studies were subjected to further analysis and 44 studies were used to make a final assessment. Summary: There is limited published evidence to support the use of a BRM in eGFR equations.


1 March 2018 in Practical Laboratory Medicine
Verified
Journal Article
Open access
RNRuth Natali
Ruth Natali
CWCara Wand
Cara Wand
KDKelly Doyle
Kelly Doyle
JNJaime H. Noguez
Jaime H. Noguez
Blood collections from peripheral intravenous catheters offer several benefits to patients, including reduced needle punctures and patient discomfort, but they risk reducing the quality of blood specimens analyzed by the laboratory. In an effort to balance analytical quality of test results with patient-centered care initiatives, a needle-less blood collection device called PIVO™ was evaluated at two institutions. The primary objective of this study was to assess the ability of the PIVO™ device to provide high-quality blood specimens for laboratory testing compared to current blood collection methods. Blood specimens drawn using the PIVO™ device were prospectively flagged. A retrospective review was performed comparing the degree and rate of hemolysis for PIVO™ blood collections to both concurrent and historical hemolysis rates for other collection methods. Approximately 7600 PIVO™ blood draws were performed across the two institutions. The hemolysis rates of samples collected with PIVO™ were evaluated using 2380 flagged collections, containing approximately 1200 test orders requiring hemolysis index measurements. The hemolysis rate of PIVO™-flagged samples (1.8%) was statistically superior to the venipuncture and central line blood collection methods (3.3%), reducing the risk of hemolysis during a venous blood draw by 39%. PIVO™ collections facilitated improvement in the rate and degree of sample hemolysis when compared to venipuncture and central line blood collections. These findings suggest that PIVO™ is capable of delivering samples that are superior to current blood collection methods in terms of hemolysis rate as well as reducing the number of invasive venipunctures required for laboratory testing.

1 April 2023 in Journal of Mass Spectrometry and Advances in the Clinical Lab
Verified
Journal Article
Open access
JNJaime H. Noguez
Jaime H. Noguez
CKChristopher D. Koch
Christopher D. Koch
•Toxicology testing provides valuable information for patient management.•Current in vitro diagnostics (IVDs) are unable to meet all clinical needs.•Lab-developed tests (LDTs) in toxicology can be used to close clinical care gaps.•LDTs in clinical toxicology are almost exclusively mass spectrometry-based methods.

1 October 2018 in Clinical Chemistry
Verified
Journal Article
Closed access
PDF file
NANansy Albtoush
Nansy Albtoush
JNJaime H. Noguez
Jaime H. Noguez
Over the past 30 years, the WHO has published 3 versions of the Laboratory Biosafety Manual to encourage the safe handling of pathogenic microorganisms in laboratories across the world. The manual has been broadly used in laboratories at all levels and biomedical sectors and is regarded as a de facto standard that represents best practices in biosafety. As technologies rapidly advance and our understanding of the potential threats and benefits to laboratory safety continue to evolve, so have our approaches to controlling exposure to pathogens. To address the current challenges relating to biological safety and security, revision and expansion of the manual toward the fourth edition are underway. In a recent article in Science by Kojima et al. (1), the authors discuss the proposed modifications …